Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

被引：0
作者：
Y. Jinnouchi
S. Yamagishi
M. Takeuchi
S. Ishida
Y. Jinnouchi
J. Jinnouchi
T. Imaizumi
机构：
[1] Kurume University School of Medicine,Department of Internal Medicine, Division of Cardio
[2] Hokuriku University,Vascular Medicine
[3] Ishida Clinic,Department of Pathophysiological Science
[4] Sasaguri Hospital,undefined
来源：
Clinical and Experimental Medicine | 2006年 / 6卷
关键词：
AGEs; Oxidative stress; Diabetes; Statin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 193
页数：2
相关论文
共 50 条
  • [21] Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease
    Bakker, S. F.
    Tushuizen, M. E.
    Gozutok, E.
    Ciftci, A.
    Gelderman, K. A.
    Mulder, C. J.
    Simsek, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 230 - 235
  • [22] Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus
    Sanchis, Pilar
    Rivera, Rosmeri
    Fortuny, Regina
    Rio, Carlos
    Mas-Gelabert, Miguel
    Gonzalez-Freire, Marta
    Grases, Felix
    Masmiquel, Luis
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 16
  • [23] Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus
    Choi, Lee-Seoul
    Ahmed, Kainat
    Kim, Young-Seol
    Yim, Jung-Eun
    HELIYON, 2022, 8 (06)
  • [24] Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes
    Aubert, C. E.
    Michel, P. -L.
    Gillery, P.
    Jaisson, S.
    Fonfrede, M.
    Morel, F.
    Hartemann, A.
    Bourron, O.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 679 - 685
  • [25] Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
    Nowotny, Kerstin
    Jung, Tobias
    Hoehn, Annika
    Weber, Daniela
    Grune, Tilman
    BIOMOLECULES, 2015, 5 (01): : 194 - 222
  • [26] Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
    Chiu, Chung-Jung
    Rabbani, Naila
    Rowan, Sheldon
    Chang, Min-Lee
    Sawyer, Sherilyn
    Hu, Frank B.
    Willett, Walter
    Thornalley, Paul J.
    Anwar, Attia
    Bar, Liliana
    Kang, Jae H.
    Taylor, Allen
    BIOFACTORS, 2018, 44 (03) : 281 - 288
  • [27] Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes
    Kato, Sayuri
    Matsumura, Takeshi
    Sugawa, Hikari
    Nagai, Ryoji
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Advanced glycation end products (AGEs) activate mast cells
    Sick, E.
    Brehin, S.
    Andre, P.
    Coupin, G.
    Landry, Y.
    Takeda, K.
    Gies, J. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (02) : 442 - 455
  • [29] Advanced glycation end products (AGEs) and their involvement in liver disease
    Hyogo, Hideyuki
    Yamagishi, Sho-ichi
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 969 - 972
  • [30] Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications
    Yamagishi, Sho-ichi
    Nakamura, Kazuo
    Imaizumi, Tsutomu
    CURRENT DIABETES REVIEWS, 2005, 1 (01) : 93 - 106
12345